Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
25.45
+0.81 (3.29%)
Apr 8, 2026, 9:25 AM EDT - Market open

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,2451,8361,1331,8331,7331,204
Market Cap Growth
85.07%62.10%-38.20%5.75%44.02%13.03%
Enterprise Value
2,1761,424551.551,2561,250777.36
Last Close Price
25.4521.0113.2221.6125.4521.89
PE Ratio
--6.39-3.55-7.25-10.3547.59
PS Ratio
13.0210.6547.84--8.61
PB Ratio
33.3228.413.933.313.712.95
P/TBV Ratio
34.1128.163.932.743.312.87
P/FCF Ratio
--5.68-4.12-11.41-12.9741.50
P/OCF Ratio
--5.69-4.12-11.41-12.9741.32
EV/Sales Ratio
12.638.2623.29--5.56
EV/EBITDA Ratio
--5.21-1.62-5.46-8.2429.60
EV/EBIT Ratio
--5.21-1.62-5.46-8.2429.65
EV/FCF Ratio
--4.41-2.01-7.82-9.3526.80
Debt / Equity Ratio
0.020.020.010.000.000.05
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.01-0.010.80
Debt / FCF Ratio
0.000.00-0.01-0.01-0.010.72
Net Debt / Equity Ratio
-6.38-6.38-2.02-1.04-1.03-1.04
Net Debt / EBITDA Ratio
1.511.511.712.513.19-16.21
Net Debt / FCF Ratio
1.271.272.113.593.62-14.68
Asset Turnover
0.280.270.04000.37
Inventory Turnover
0.420.424.51---
Quick Ratio
4.014.015.749.9416.7921.60
Current Ratio
4.404.405.8210.0016.8521.68
Return on Equity (ROE)
-161.82%-161.82%-75.69%-40.98%-34.10%7.55%
Return on Assets (ROA)
-43.54%-43.54%-50.78%-41.43%-32.05%6.99%
Return on Invested Capital (ROIC)
-820.60%-820.60%-1220.50%1517.50%917.13%-213.93%
Return on Capital Employed (ROCE)
-52.98%-52.98%-57.76%-44.96%-33.83%7.38%
Earnings Yield
-12.72%-15.66%-28.14%-13.79%-9.67%2.10%
FCF Yield
-14.40%-17.60%-24.27%-8.76%-7.71%2.41%
Buyback Yield / Dilution
-1.17%-1.17%-21.67%-15.82%-13.31%-29.81%
Total Shareholder Return
-1.17%-1.17%-21.67%-15.82%-13.31%-29.81%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q